0
What is the maximum plasma level of tamoxifen that can be achieved in breast cancer patients?
- 1 people answered
0 Vote
1 Contributor
1337 Views 
0 Saved
0 Vote 1 Contributor1337 Views 0 SavedYou might also be interested in
No, not every cancer patient needs chemotherapy. Treatment depends on the type and stage of cancer. Some may need surgery, radiation, or newer therapies like immunotherapy. Your doctor will recommend the best plan for your condition. I’m scared chemotherapy will make me lose my hair. Is there any....
Yes...There are many stories with happy ending. Chemo is not the end of your life. Every day is a gift... that's what chemo reminds you. The majority of women who develop breast cancer around the world will not die of breast cancer. In fact, 8 out of 10 women who are diagnosed with breast cancer wil....
Breast cancer can be diagnosed at different stages and can grow at different rates. This means people can have different treatments, depending on what will work best for them. To determine if your symptoms are caused by breast cancer or a benign breast condition, your doctor will do a thorough ph....
Mithun Kumar
Tamoxifen is a highly effective endocrine treatment for breast cancer in the adjuvant and metastatic settings. Data from several large randomized clinical trials indicate that tamoxifen is also valuable in the prevention of breast cancer in women at high risk for the disease. However, not all women benefit from tamoxifen, and the side effect profiles vary considerably from patient to patient.
Tamoxifen treatment promotes significant changes both in the plasma concentration of an important marker associated with an increased risk of Cardio Vascular Disease (CVD) and in functional parameters of cardiac performance in women with breast cancer who have previously undergone chemotherapy. Previous studies had also confirmed the cardiotoxic effects of chemotherapy.
Chronic use of tamoxifen significantly reduces the plasma concentrations of CVD biomarkers (CRP, Apo B, and the Apo-B/Apo-A ratio) in women with breast cancer who underwent chemotherapy. Several study suggests the need for a careful cardiovascular evaluation and the medical monitoring of women with breast cancer to reduce the morbidity and mortality associated with cancer treatment complications.